153 related articles for article (PubMed ID: 7682758)
1. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.
Nickoloff BJ; Mitra RS; Lee K; Turka LA; Green J; Thompson C; Shimizu Y
Am J Pathol; 1993 Apr; 142(4):1029-40. PubMed ID: 7682758
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.
Freedman AS; Freeman GJ; Rhynhart K; Nadler LM
Cell Immunol; 1991 Oct; 137(2):429-37. PubMed ID: 1716521
[TBL] [Abstract][Full Text] [Related]
3. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley PS; Clark EA; Ledbetter JA
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5031-5. PubMed ID: 2164219
[TBL] [Abstract][Full Text] [Related]
4. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
[TBL] [Abstract][Full Text] [Related]
5. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.
Freeman GJ; Cardoso AA; Boussiotis VA; Anumanthan A; Groves RW; Kupper TS; Clark EA; Nadler LM
J Immunol; 1998 Sep; 161(6):2708-15. PubMed ID: 9743327
[TBL] [Abstract][Full Text] [Related]
6. CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis.
Life P; Aubry JP; Estoppey S; Schnuriger V; Bonnefoy JY
Eur J Immunol; 1995 Feb; 25(2):333-9. PubMed ID: 7533083
[TBL] [Abstract][Full Text] [Related]
7. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
9. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
10. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
[TBL] [Abstract][Full Text] [Related]
12. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions.
Wyss-Coray T; Mauri-Hellweg D; Baumann K; Bettens F; Grunow R; Pichler WJ
Eur J Immunol; 1993 Sep; 23(9):2175-80. PubMed ID: 7690323
[TBL] [Abstract][Full Text] [Related]
13. Requirements for CD28-dependent T cell-mediated cytotoxicity.
Azuma M; Cayabyab M; Phillips JH; Lanier LL
J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
[TBL] [Abstract][Full Text] [Related]
14. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Linsley PS; Aruffo A; Ledbetter JA
J Immunol; 1992 Oct; 149(8):2541-8. PubMed ID: 1383317
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a novel anti-B7 monoclonal antibody.
de Boer M; Parren P; Dove J; Ossendorp F; van der Horst G; Reeder J
Eur J Immunol; 1992 Dec; 22(12):3071-5. PubMed ID: 1280221
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.
Nickoloff BJ; Nestle FO; Zheng XG; Turka LA
Blood; 1994 May; 83(9):2580-6. PubMed ID: 7513205
[TBL] [Abstract][Full Text] [Related]
17. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
Carreno BM; Collins M
Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
19. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity.
Van Gool SW; de Boer M; Ceuppens JL
J Immunol; 1993 Apr; 150(8 Pt 1):3254-63. PubMed ID: 7682237
[TBL] [Abstract][Full Text] [Related]
20. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS
J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
